Acute Effects of Dietary Proteins on Postprandial Lipemia, Incretin Responses and Subclinical Inflammation in Obese Subjects

Sponsor
Aarhus University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT00863564
Collaborator
The Danish Obesity Research Centre (Other), Nordic Centre of Excellence (Other)
12
1
4
7
1.7

Study Details

Study Description

Brief Summary

The purpose of this study is to determine the effects of dietary protein on blood lipids and gut hormones after a fat-rich meal.

Hypothesis: Certain dietary proteins reduce the amount of fat circulating in the blood stream following a fat rich meal. The effect is dependant of both the quality and the quantity of protein ingested.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Caseine
  • Dietary Supplement: Cod
  • Dietary Supplement: Gluten
  • Dietary Supplement: Whey Isolate
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
12 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
Acute Effects of Dietary Proteins on Postprandial Lipemia, Incretin Responses and Subclinical Inflammation in Obese Subjects
Study Start Date :
Mar 1, 2009
Actual Primary Completion Date :
Oct 1, 2009
Actual Study Completion Date :
Oct 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Whey Isolate

Dietary Supplement: Whey Isolate

Active Comparator: Caseine

Dietary Supplement: Caseine

Active Comparator: Cod

Dietary Supplement: Cod

Active Comparator: Gluten

Dietary Supplement: Gluten

Outcome Measures

Primary Outcome Measures

  1. Triglyceride [0h- 2h- 4h- 6h- 8h postprandial]

Secondary Outcome Measures

  1. Incretins [0h -1h -2h -4h -6h -8h Postprandial]

  2. Inflammatory markers [0h- 1h- 2h- 4h- 6h- 8h postprandial]

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • BMI > 30 kg/m2 & < 45 kg/m2
Exclusion Criteria:
  • Diabetes

  • Lipid lowering drugs

  • Liver-, Kidney- and/or Heart Disease

  • Serious Hypertension (160/110)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Clinical Nutrion Aarhus Denmark 8000

Sponsors and Collaborators

  • Aarhus University Hospital
  • The Danish Obesity Research Centre
  • Nordic Centre of Excellence

Investigators

  • Principal Investigator: K Hermansen, Professor, MD, Department of Endocrinology and Metabolism, Aarhus University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00863564
Other Study ID Numbers:
  • CERN-PPL-JHJ-5a
First Posted:
Mar 18, 2009
Last Update Posted:
Nov 10, 2009
Last Verified:
Nov 1, 2009

Study Results

No Results Posted as of Nov 10, 2009